Macfarlanes advises Sterling Pharma Solutions on the funding for its acquisition of US specialist manufacturing facility

The acquisition will facilitate a larger US presence for Sterling Pharma Solutions and will provide additional capacity for development and manufacturing projects, specifically those with complex and hazardous requirements. 

 The Germantown facility houses state-of-the-art development, scale-up and manufacturing facilities and has specialist expertise in handling technologies including plant-scale hydrogenation and cryogenic reactions.

The Macfarlanes team for this matter was led by corporate and M&A partner Alex Edmondson with assistance from senior solicitor Felicity Powell and finance solicitor Owen Giles.

Alex Edmondson comments: “We are pleased to have acted for Sterling Pharma Solutions in relation to the acquisition of a facility which will support their growth strategy in the US market.”